Home
/
EKSO BIONICS HOLDINGS, INC.
/
Financials
/
Quarterly
EKSO BIONICS HOLDINGS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that EKSO BIONICS HOLDINGS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$2.97M
Aug 7, 2018
Q1
2018
Mar 31, 2018
$2.52M
May 7, 2018
Q2
2018
Jun 30, 2017
$1.87M
Aug 7, 2018
Q1
2013
Jun 30, 2013
$0
Aug 15, 2013
Q3
2012
Dec 31, 2012
$0
Feb 20, 2013
Q2
2012
Sep 30, 2012
$0
Dec 13, 2012
Q1
2013
Jun 30, 2012
$0
Aug 15, 2013
Q2
2012
Jun 30, 2012
$0
Nov 13, 2012
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$2.52M
May 7, 2018
Q3
2017
Sep 30, 2017
$1.60M
Nov 8, 2017
Q2
2017
Jun 30, 2017
$1.87M
Aug 7, 2017
Q1
2018
Mar 31, 2017
$1.44M
May 7, 2018
Q3
2017
Sep 30, 2016
$1.60M
Nov 8, 2017
Q2
2017
Jun 30, 2016
$1.55M
Aug 7, 2017
Q1
2017
Mar 31, 2016
$8.49M
May 9, 2017
Q3
2016
Sep 30, 2015
$2.92M
Nov 9, 2016
Q2
2016
Jun 30, 2015
$2.11M
Aug 3, 2016
Q1
2016
Mar 31, 2015
$1.69M
May 10, 2016
Q3
2015
Sep 30, 2014
$1.59M
Nov 9, 2015
Q2
2015
Jun 30, 2014
$1.20M
Aug 12, 2015
Q1
2015
Mar 31, 2014
$1.06M
May 11, 2015
Q3
2014
Sep 30, 2013
$833.8K
Nov 12, 2014
Q2
2014
Jun 30, 2013
$984.0K
Aug 8, 2014
Q1
2014
Mar 31, 2013
$696.2K
May 13, 2014
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.42M)
Oct 28, 2025
Q2
2025
Jun 30, 2025
($2.71M)
Jul 28, 2025
Q3
2025
Jun 30, 2025
($2.71M)
Oct 28, 2025
Q3
2025
Mar 31, 2025
($2.89M)
Oct 28, 2025
Q2
2025
Mar 31, 2025
($2.89M)
Jul 28, 2025
Q1
2025
Mar 31, 2025
($2.89M)
May 5, 2025
Q3
2025
Sep 30, 2024
($2.07M)
Oct 28, 2025
Q2
2025
Jun 30, 2024
($2.42M)
Jul 28, 2025
Q3
2025
Jun 30, 2024
($2.42M)
Oct 28, 2025
Q2
2025
Mar 31, 2024
($3.43M)
Jul 28, 2025
Q1
2025
Mar 31, 2024
($3.43M)
May 5, 2025
Q3
2025
Mar 31, 2024
($3.43M)
Oct 28, 2025
Q3
2024
Sep 30, 2023
($3.37M)
Oct 28, 2024
Q2
2024
Jun 30, 2023
($4.23M)
Jul 29, 2024
Q3
2024
Jun 30, 2023
($4.23M)
Oct 28, 2024
Q1
2024
Mar 31, 2023
($4.39M)
Apr 29, 2024
Q2
2024
Mar 31, 2023
($4.39M)
Jul 29, 2024
Q3
2024
Mar 31, 2023
($4.39M)
Oct 28, 2024
Q3
2023
Sep 30, 2022
($4.30M)
Oct 26, 2023
Q3
2023
Jun 30, 2022
($2.98M)
Oct 26, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.40M)
Oct 28, 2025
Q2
2025
Jun 30, 2025
($3.98M)
Jul 28, 2025
Q1
2025
Mar 31, 2025
($3.44M)
May 5, 2025
Q3
2025
Sep 30, 2024
($2.64M)
Oct 28, 2025
Q2
2025
Jun 30, 2024
($2.34M)
Jul 28, 2025
Q1
2025
Mar 31, 2024
($3.26M)
May 5, 2025
Q3
2024
Sep 30, 2023
($2.93M)
Oct 28, 2024
Q2
2024
Jun 30, 2023
($4.28M)
Jul 29, 2024
Q1
2024
Mar 31, 2023
($4.45M)
Apr 29, 2024
Q3
2023
Sep 30, 2022
($3.65M)
Oct 26, 2023
Q2
2023
Jun 30, 2022
($3.23M)
Jul 27, 2023
Q1
2023
Mar 31, 2022
($4.24M)
Apr 27, 2023
Q3
2022
Sep 30, 2021
($2.79M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($3.35M)
Jul 28, 2022
Q1
2021
Mar 31, 2021
($3.14M)
Apr 28, 2022
Q3
2021
Sep 30, 2020
($2.42M)
Nov 2, 2021
Q2
2021
Jun 30, 2020
($3.09M)
Jul 29, 2021
Q1
2021
Mar 31, 2020
($4.78M)
Apr 29, 2021
Q3
2020
Sep 30, 2019
($3.79M)
Oct 29, 2020
Q2
2020
Jun 30, 2019
($5.10M)
Jul 30, 2020